Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04489238 · ClinicalTrials.gov registry record
Collection of Information to Better Understand Young Onset Colorectal Cancer
A clinical trial of Colorectal Cancer and Colorectal Carcinoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 1,366
- Enrollment target
- 8
- Study locations
NCT04489238 is a study of Colorectal Cancer and Colorectal Carcinoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,366 participants, roughly in line with the 1,508-participant average among 369 other Colorectal Cancer trials with a reported enrollment target. The trial reports 8 study locations across 2 states.
The verdict
NCT04489238, a study of Colorectal Cancer and Colorectal Carcinoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 1,366 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this registry study is to create a database-a collection of information-for better understanding young onset colorectal cancer. Colorectal cancer patients are considered to have young onset colorectal cancer if they are diagnosed with their cancer before the age of 50. Researchers will use the information from this database to learn more about how young onset colorectal cancer may be similar to or different from colorectal cancer that is diagnosed later in life. Researchers will also use information from the database for current and future research on young onset colorectal cancer.
Conditions Studied
Interventions
- OTHER Risk Factor Questionnaire
Study Locations (8)
New York
- Memorial Sloan Kettering Cancer Center @ Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- MSK at Ralph Lauren - New York
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,366 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2026-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04489238
The ClinicalTrials.gov registry entry for NCT04489238 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,366 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,508-participant average among 369 other Colorectal Cancer trials with a reported enrollment target. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Risk Factor Questionnaire is the first listed.
NCT04489238 reports 8 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT04489238 about?
NCT04489238 is a clinical study titled "Collection of Information to Better Understand Young Onset Colorectal Cancer". The purpose of this registry study is to create a database-a collection of information-for better understanding young onset colorectal cancer. Colorectal cancer patients are considered to have young onset colorectal cancer if they are diagnosed with their cancer before the age of 50. Researchers wil...
What is the current status of trial NCT04489238?
This trial is currently recruiting. The enrollment target is 1,366 participants. The study started on 2020-07-22. Estimated completion is 2026-07-22.
What conditions does trial NCT04489238 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Carcinoma.
What interventions are being tested in trial NCT04489238?
The interventions under investigation include: Risk Factor Questionnaire (OTHER).
Who is sponsoring clinical trial NCT04489238?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04489238 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.